---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "mg3X2jRvTiDgl7U7+j3AE+2lela/EXuNkcaBlCXE1q3wh+7ITug+fN9zZWNV7FhIsp2f50MEUfI+4JNBBxq+p4Hl5aCZLr1+v9mfwn2hhxo7nmApErg7PYDq8IspmsUS8xoio/jclK1arPMvzrV+VF9S+2mlujUcoMjZeAhEOULUZveegcvF5LZ3+PuaHtyk/oXtZkyfiJBMq3CCRtSE6f3T5eLxPuZ3WpN9iDUM6S6mOyY3l74YW9s4d9MA0zyWqnniePk5PXmLgK19RtdcztaWBhm43C9jwcNqzibWsUIln36WCDSZ5ztnBPAYYd/J;3dC7IVIeavVJIv8u8EaHkw=="
---

